Bivalent booster demonstrates superior antibody response against Omicron: Moderna Ruchika Sharma9 Jun 2022 3:17 PM IST"Moderna is planning to submit the interim analysis and data to regulators for review in the coming weeks," the company further stated.
Women more likely to develop skin rash from Moderna COVID vaccine, says Japanese study Roshni Dhar3 Jun 2022 6:00 PM ISTA study in Japan found that women were significantly more likely than men to develop rash-like side effects after a first dose of Moderna Inc's...
Health Bulletin 3/June/2022 Roshni Dhar3 Jun 2022 5:29 PM ISTHere are the top health stories of the day:Use khadi, wear khadi: NMC advises doctors, medical colleges, hospitalStressing the need to encourage the...
Women more likely to develop skin rash from Moderna COVID vaccine: Japanese study Ruchika Sharma2 Jun 2022 4:13 PM ISTThe symptoms were mild and not considered a contraindication of the mRNA-based vaccine, according to the June 1 report in the Journal of the American...
Moderna gets back Spikevax marketing rights in Japan Ruchika Sharma1 Jun 2022 10:00 AM ISTIn Japan, Spikevax is indicated for the prevention of coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2.
Monkeypox: Moderna testing vaccines in pre-clinical trials Ruchika Sharma26 May 2022 12:19 PM ISTNew Delhi: Moderna Inc is testing potential vaccines against monkeypox in pre-clinical trials as the disease spreads in the United States...
Moderna concludes USFDA submission for use of COVID vaccine in adolescents, kids Ruchika Sharma15 May 2022 9:30 AM ISTNew Delhi: Moderna Inc has made all necessary submissions required by the U.S. Food & Drug Administration for emergency use authorization of its...
COVID vaccine makers shift focus to booster shots Ruchika Sharma10 May 2022 11:00 AM ISTPfizer Chief Executive Albert Bourla said in an interview that adults who are still unvaccinated are unlikely to seek out shots now, more than two...
COVID-19: WHO backed vaccine resolution wins 24 percent support at Moderna Ruchika Sharma1 May 2022 9:30 AM ISTThe message for management from the result is "there are more important things to think about than just returns to investors," Hodgson said.
Moderna seeks USFDA emergency use nod for COVID vaccine in children younger than 6 Ruchika Sharma29 April 2022 11:59 AM ISTModerna is also currently studying booster doses for all pediatric cohorts.
Moderna to file for COVID vaccine EUA for children under 6 Ruchika Sharma22 April 2022 10:53 AM ISTNew Delhi: Moderna plans to submit an application to the US health regulator for emergency use authorization (EUA) of its Covid-19 vaccine among kids...
Moderna new COVID vaccine shows promise against Omicron much more than existing shots MD Bureau21 April 2022 12:21 PM ISTA 50-microgram dose of Moderna's new vaccine doubled the antibodies, which block the virus from infecting human cells, against the Omicron variant six...
